Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Asthma Clinical Trial

Official title:

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06449573
• Other study ID #: GO 23/533
• Status: Recruiting
• Start date: March 1, 2024
• Est. completion date: July 2024

Study information

• Verified date: June 2024
• Source: Hacettepe University
• Contact: Aydan Asli Aksel Uylar
• Phone: +90312
• Email: aydanaaksel[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

Description:

It is thought that aerobic capacity of asthmatic individuals decreases due to chronic respiratory disease, especially oxygen consumption. Detailed investigation will be provided with this research.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 15
• Est. completion date: July 2024
• Est. primary completion date: July 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• No respiratory, cardiovascular and metabolic diseases

• Regular non-smoker

Exclusion Criteria:

• Non-consenting

• Pregnant women

Related Conditions & MeSH terms

• Asthma

Intervention

Other:
• Exercise capacity
cardiopulmonary exercise test used assessment of exercise capacity

Locations

Country	Name	City	State
Turkey	Hacettepe University	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exercise capacity	Exercise capacity will be assessed by Cardiopulmonary Exercise Test. The test will be performed on a bicycle ergometer. The test will be terminated when the target heart rate is reached or when the patient indicates that they are unable to continue the test. maximal oxygen consumption and the workload achieved will be recorded.	20 minutes
Secondary	Respiratory muscle strength	Inspiratory and expiratory muscle strength will be measured with a mouth pressure measuring device. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright.	8 minutes
Secondary	Peripheral muscle strength	It will be evaluated with a portable manual muscle strength measuring device. Muscle strength of knee extensors will be measured. The measurement will be performed with the patient sitting with his/her back unsupported and his/her hands crossed on his/her chest.	5 minutes
Secondary	Grip strength	It will be evaluated with a portable hand dynamometer. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright. The measurement will be performed with the arm adjacent to the side of the trunk and the forearm parallel to the ground.	3 minutes
Secondary	Kinesiophobia	Tampa Kinesiophobia Scale will be used. A total of 17 questions will be answered in 4-point Likert form. In total, the patient scores between 17-68. A high score indicates high kinesiophobia.	3 minutes
Secondary	Quality of Life (symptoms, mood, activity limitation, environmental exposure)	Asthma Quality of Life Scale will be used for the evaluation. This scale consists of 4 sub-headings including symptoms, mood, activity limitation, environmental exposure and 32 questions. Each item is scored between 1-7. The total score of the scale is calculated by averaging the scores given to the items. The higher the score, the better the quality of life.	10 minutes